Caesars is scheduled to report its Q1 2026 results today, , after the market closes.
The average 12-month price target is approximately $32.73 to $32.93 , representing a forecasted upside of about 17% from the current price of $28.03 . Recent Adjustments: czr stock buy or sell
JPMorgan Chase & Co. recently lowered its target slightly from $36.00 to (Overweight). Caesars is scheduled to report its Q1 2026
Morgan Stanley holds an (Hold) rating with a $34.00 target. Key Financial Performance (Q1 2026) czr stock buy or sell
Generally rated as a Buy or Moderate Buy , with roughly 62%–79% of covering analysts recommending a purchase.